Literature DB >> 24098053

Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis.

Jason S Ellis1, So-Hee Hong, Habib Zaghouani, Helen Braley-Mullen.   

Abstract

NOD.H-2h4 mice given NaI in their drinking water develop iodine-accelerated spontaneous autoimmune thyroiditis (ISAT) with chronic inflammation of the thyroid by T and B cells and production of anti-mouse thyroglobulin (MTg) autoantibody. CD28(-/-) NOD.H-2h4 mice, which have reduced numbers of CD4(+)Foxp3(+) regulatory T cells (Tregs), were developed to examine the role of Tregs in ISAT development. CD28(-/-) NOD.H2-h4 mice develop more severe ISAT than do wild-type (WT) mice, with collagen deposition (fibrosis) and low serum T4. CD28(-/-) mice have increased expression of proinflammatory cytokines IFN-γ and IL-6, consistent with increased mononuclear cell infiltration and tissue destruction in thyroids. Importantly, transferring purified CD4(+)Foxp3(+) Tregs from WT mice reduces ISAT severity in CD28(-/-) mice without increasing the total number of Tregs, suggesting that endogenous Tregs in CD28(-/-) mice are functionally ineffective. Endogenous CD28(-/-) Tregs have reduced surface expression of CD27, TNFR2 p75, and glucocorticoid-induced TNFR-related protein compared with transferred CD28(+/+) Tregs. Although anti-MTg autoantibody levels generally correlate with ISAT severity scores in WT mice, CD28(-/-) mice have lower anti-MTg autoantibody responses than do WT mice. The percentages of follicular B cells are decreased and those of marginal zone B cells are increased in spleens of CD28(-/-) mice, and they have fewer thyroid-infiltrating B cells than do WT mice. This suggests that CD28 deficiency has direct and indirect effects on the B cell compartment. B cell-deficient (B(-/-)) NOD.H-2h4 mice are resistant to ISAT, but CD28(-/-)B(-/-) mice develop ISAT comparable to WT mice and have reduced numbers of Tregs compared with WT B(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24098053      PMCID: PMC3818309          DOI: 10.4049/jimmunol.1301253

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice.

Authors:  H Braley-Mullen; G C Sharp; B Medling; H Tang
Journal:  J Autoimmun       Date:  1999-05       Impact factor: 7.094

2.  Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice.

Authors:  L Rasooly; C L Burek; N R Rose
Journal:  Clin Immunol Immunopathol       Date:  1996-12

Review 3.  Marginal zone B cells.

Authors:  Shiv Pillai; Annaiah Cariappa; Stewart T Moran
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 4.  The B7 family revisited.

Authors:  Rebecca J Greenwald; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  CD28-deficient mice are highly resistant to collagen-induced arthritis.

Authors:  Y Tada; K Nagasawa; A Ho; F Morito; O Ushiyama; N Suzuki; H Ohta; T W Mak
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

6.  Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene-disrupted mice.

Authors:  H Tang; G C Sharp; K E Peterson; H Braley-Mullen
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

Review 7.  CD28/B7 system of T cell costimulation.

Authors:  D J Lenschow; T L Walunas; J A Bluestone
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

8.  CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.

Authors:  D J Lenschow; K C Herold; L Rhee; B Patel; A Koons; H Y Qin; E Fuchs; B Singh; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1996-09       Impact factor: 31.745

9.  B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis.

Authors:  K E Peterson; G C Sharp; H Tang; H Braley-Mullen
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

10.  Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice.

Authors:  Sandra M McLachlan; Helen Braley-Mullen; Chun-Rong Chen; Holly Aliesky; Pavel N Pichurin; Basil Rapoport
Journal:  Endocrinology       Date:  2004-09-30       Impact factor: 4.736

View more
  10 in total

1.  Regulatory T cells in B-cell-deficient and wild-type mice differ functionally and in expression of cell surface markers.

Authors:  Jason S Ellis; Helen Braley-Mullen
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

2.  Cross-reactivity of antigens and antibodies belonging to different pathogenic types of human papillomaviruses.

Authors:  R K Salyaev; N I Rekoslavskaya; A S Stolbikov
Journal:  Dokl Biochem Biophys       Date:  2018-01-03       Impact factor: 0.788

3.  New Murine Model of Early Onset Autoimmune Thyroid Disease/Hypothyroidism and Autoimmune Exocrinopathy of the Salivary Gland.

Authors:  Timothy Daniel Kayes; Gary A Weisman; Jean M Camden; Lucas T Woods; Cole Bredehoeft; Edward F Downey; James Cole; Helen Braley-Mullen
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

4.  Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase.

Authors:  Rajni Sharma; Giulia Di Dalmazi; Patrizio Caturegli
Journal:  Thyroid       Date:  2016-07-22       Impact factor: 6.568

5.  Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.

Authors:  Naris Nilubol; ZiQiang Yuan; Giulio F Paciotti; Lawrence Tamarkin; Carmen Sanchez; Kelli Gaskins; Esther M Freedman; Shugeng Cao; Jielu Zhao; David G I Kingston; Steven K Libutti; Electron Kebebew
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

6.  Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.

Authors:  O Toker; M Berger; O Shamriz; A J Simon; A Lev; O Megged; O Ledder; E Picard; L Joseph; V Molho-Pessach; Y Tal; P Millman; M Slae; R Somech
Journal:  Clin Exp Immunol       Date:  2020-04-18       Impact factor: 4.330

7.  Evidence that MHC I-E dampens thyroid autoantibodies and prevents spreading to a second thyroid autoantigen in I-A(k) NOD mice.

Authors:  A-N Pelletier; H A Aliesky; B Banuelos; G Chabot-Roy; B Rapoport; S Lesage; S M McLachlan
Journal:  Genes Immun       Date:  2015-03-26       Impact factor: 2.676

Review 8.  The Potential Roles of Bisphenol A (BPA) Pathogenesis in Autoimmunity.

Authors:  Datis Kharrazian
Journal:  Autoimmune Dis       Date:  2014-04-07

Review 9.  Iodine excess as an environmental risk factor for autoimmune thyroid disease.

Authors:  Yuqian Luo; Akira Kawashima; Yuko Ishido; Aya Yoshihara; Kenzaburo Oda; Naoki Hiroi; Tetsuhide Ito; Norihisa Ishii; Koichi Suzuki
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923

Review 10.  Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases.

Authors:  Ning Huang; Hongbin Chi; Jie Qiao
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.